Home/Filings/4/0001127602-21-028575
4//SEC Filing

Baldasare Bryan T 4

Accession 0001127602-21-028575

CIK 0000794172other

Filed

Nov 7, 7:00 PM ET

Accepted

Nov 8, 4:09 PM ET

Size

6.9 KB

Accession

0001127602-21-028575

Insider Transaction Report

Form 4
Period: 2021-11-04
Baldasare Bryan T
Chief Accounting Officer
Transactions
  • Award

    Stock Options (Right to Buy)

    2021-11-04+11,66911,669 total
    Exercise: $18.88Exp: 2031-11-04Common Stock (11,669 underlying)
  • Award

    Common Stock

    2021-11-04+10,59366,721 total
Footnotes (2)
  • [F1]These restricted stock units are awarded under the 2021 Omnibus Award Plan and vest in four equal installments from the date of grant (i.e., vest 25% per year until fully vested on November 4, 2025).
  • [F2]These non-qualified options are awarded under the 2021 Omnibus Award Plan and vest as follows: (i) 25% of the options awarded vest on November 4, 2022; and (ii) the remaining 75% of the options awarded vest pro rata each month from November 4, 2022 through November 4, 2025.

Issuer

MERIDIAN BIOSCIENCE INC

CIK 0000794172

Entity typeother

Related Parties

1
  • filerCIK 0001761920

Filing Metadata

Form type
4
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 4:09 PM ET
Size
6.9 KB